Glenmark Life Sciences Q2 Results

  • BSE: 543322
  • NSE: GLS
  • ISIN: INE03Q201024
  • Sector: Biotechnology & Drugs
BSE
834.35-7.05 (-0.84%)
Volume11.18 K
Updated: Mon 27 May, 2024 | 15:40:55
NSE
831.95-8.25 (-0.98%)
Volume55.44 K
Updated: Mon 27 May, 2024 | 15:42:46
Today: 824.60
845.00
52-Wk: 512.70
904.20

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Glenmark Life Sciences Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 1,882.782,478.23-24.03%
    Selling/ General/ Admin Expenses Total 161.74168.29-3.89%
    Depreciation/ Amortization 61.7460.242.49%
    Other Operating Expenses Total 38.1946.42-17.73%
    Total Operating Expense 1,477.461,931.11-23.49%
    Operating Income 405.32547.12-25.92%
    Net Income Before Taxes 287.09431.80-33.51%
    Net Income 217.16309.84-29.91%
    Diluted Normalized EPS 22.4532.05-29.95%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App